Ribosomal protein L7 pseudogene 26 (RPL7P26)

Ribosomal protein L7 pseudogene 26 (RPL7P26) is a processed pseudogene located in the human genome, arising from the duplication or retrotransposition of the functional ribosomal protein L7 (RPL7) gene[5][1][6]. Pseudogenes like RPL7P26 generally do not produce functional proteins and lack a known biological function in normal or disease physiology[5][6]. RPL7P26 is not considered a therapeutic target, as it does not encode a functional protein and has no established interactions with drugs or biomarkers. Its primary utility may be in genomic studies understanding the evolution and distribution of ribosomal protein pseudogenes and in distinguishing functional genes from non-functional genomic elements[6].\n- This entry is *not* a therapeutic target.\n- It is a pseudogene (non-protein coding), not an active ribosomal protein, receptor, enzyme, or disease-related target[5][6].\n- The abbreviation **RPL7P26** is canonical.\n- The most common alias is **RPL7_9_661**[1][5].\n- Pseudogenes are generally classified as "Other" for molecular function.\n- There are no known functions, drug interactions, safety risks, or disease associations reported in reputable databases for RPL7P26[5][1].\nIf you intended to reference the functional protein **RPL7** (Ribosomal protein L7), which is a component of the 60S ribosomal subunit and has documented biological roles and disease links (e.g., lupus autoantigen)[3], clarification is needed. In its current form, RPL7P26 is a non-target pseudogene, and the above data reflects that[5][1][6].

Other names

RPL7_9_661